Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
Sivan Seliktar-Ofir(Sheba Medical Center), Michal J. Besser(Tel Aviv University)
Cited by 69
Related Papers
TIL therapy broadens the tumor-reactive CD8<sup>+</sup>T cell compartment in melanoma patients
|OncoImmunology|2012|176
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness
|Cancer Cell|2024|17
Genetic Modification of Tumor-Infiltrating Lymphocytes via Retroviral Transduction
|Frontiers in Immunology|2021|11